-
1 week ago | 
caixinglobal.com | Chen Xi |Han Wei
Explore the story in 3 minutesChina’s innovative drug industry, after enduring several years of shrinking valuations and a near halt in IPO activity, is displaying early signs of a rebound. This resurgence is evidenced by major cross-border licensing deals that have reignited global attention and lifted sector stock prices, indicating a potential positive shift.
-
1 week ago | 
caixinglobal.com | Chen Xi |Han Wei
00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
After years of falling valuations and stalled IPO activity, China’s innovative drug industry is showing early signs of a comeback. A spate of large-scale cross-border licensing deals is rekindling global interest and lifting stock prices, suggesting a possible shift in momentum for the sector.
-
1 week ago | 
caixinglobal.com | Chen Xi |Han Wei
Explore the story in 3 minutesA wave of multibillion-dollar deals is dramatically reshaping the pharmaceutical industry, as major international players like Pfizer Inc. and Bristol Myers Squibb Co. increasingly turn to China’s rapidly developing biotech sector in search of the next major drug breakthroughs.
-
1 week ago | 
caixinglobal.com | Chen Xi |Han Wei
Explore the story in 3 minutes1. In recent months, China’s biotechnology sector has experienced a surge in international recognition, with major global pharmaceutical firms entering multi-billion-dollar deals to license innovative therapies from Chinese companies. These landmark agreements signify a pivotal advancement in China’s status within global drug development and have sparked intense investor interest in the sector [para. 1]. 2.
-
1 week ago | 
caixinglobal.com | Chen Xi |Han Wei
In a resounding vote of confidence in China’s biotechnology sector, leading global pharmaceutical companies are striking multi-billion-dollar deals for innovative therapies developed by Chinese firms. These deals mark a pivotal point for China’s role in global drug development and have sparked a capital market frenzy.
In late May, Pfizer Inc. agreed to pay $1.25 billion upfront to 3SBio Inc., a Shenyang-based biotech firm, for the rights to a promising anti-tumor drug.
-
1 month ago | 
globaltimes.cn | Chen Xi |Xu Liuliu |Ji Yuqiao
The pursuit of beauty has been a timeless thread weaving throughout human history. The distinct beauty of Chinese aesthetics is not only embodied in every aspect of Chinese life, but also increasingly bringing spiritual enjoyment to people of all cultural backgrounds in the form of artistic expression. The vibrant neo-Chinese aesthetics is taking hold, blending the rich Chinese heritage with contemporary creativity, offering a unique aesthetic experience, and enriching people's spiritual world.
-
1 month ago | 
globaltimes.cn | Xu Liuliu |Chen Xi |Ji Yuqiao
Visitors watch An Era in Jinling, a digital show inspired by a scroll painting depicting the ancient urban landscape of Nanjing. Photos on this page: IC A creative product of the Egypt exhibition at the Shanghai Museum As the International Museum Day is just around the corner, the Shanghai Museum announced a challenge to set a world record - launching a "Sleepless Night" mode for On Top of the Pyramid: The Civilization of Ancient Egypt exhibition.
-
1 month ago | 
globaltimes.cn | Ji Yuqiao |Chen Xi
The scenic view of the Badaling Great Wall in Beijing Photos on this page: VCGA visitor with exoskeleton climbing device At dusk, the dazzling lights began to turn on, and the Badaling Great Wall in Beijing stretches like a grand golden dragon. Exhibitions of Hanfu culture, performances of traditional instruments such as guzheng, and dance shows attracted many visitors to gather and watch.
-
1 month ago | 
globaltimes.cn | Ji Yuqiao |Chen Xi
An aerial view of Taxkorgan Tajik Autonomous County Photo: ICAt 4pm, the first cinema in the Taxkorgan Tajik Autonomous County in Kashi Prefecture, Northwest China's Xinjiang Uygur Autonomous Region opened at the appointed time. The cleaner had already swept both screening rooms, and the ticket seller - hired by the manager He Xinyu due to the ability to speak both Tajik and Putonghua - was prepared to welcome local filmgoers from various ethnic groups.
-
2 months ago | 
caixinglobal.com | Chen Xi |Jiang Moting |Kelly Wang
Explore the story in 3 minutesChinese innovative drug developers are embracing the "NewCo" model to expand globally amidst a domestic capital shortage, driving international collaboration and funding opportunities for innovative drugs. The NewCo approach involves forming overseas entities in partnership with foreign investors, licensing international rights for drug candidates while retaining equity in the new companies.
